BIIB logo

BIIB

Biogen Inc.

$132.22
-$0.43(-0.32%)
76
Overall
80
Value
72
Tech
--
Quality
Market Cap
$20.05B
Volume
1.08M
52W Range
$110.04 - $206.70
Target Price
$170.24
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$10.5B$11.1B$11.9B$12.9B$13.7B$12.7B$11.0B$10.2B$9.8B$9.7B
Total Revenue
$10.8B$11.4B$12.3B$13.5B$14.4B$13.4B$11.0B$10.2B$9.8B$9.7B
COST OF GOODS SOLD
Cost of Revenue
$1.2B$1.5B$1.6B$1.8B$2.0B$1.8B$2.1B$2.3B$2.5B$2.3B
GROSS PROFIT
Gross Profit
$9.5B$10.0B$10.6B$11.6B$12.4B$11.6B$8.9B$7.9B$7.3B$7.4B
OPERATING EXPENSES
Operating Expenses
$4.5B$-4.3B$-5.1B$-5.6B$-5.4B$-7.2B$5.2B$5.0B$5.0B$4.4B
Research & Development
$2.0B$2.0B$-2.3B$-2.6B$2.3B$-4.0B$2.5B$2.2B$2.5B$2.0B
Research Expense
------------$2.5B$2.2B$2.5B$2.0B
Selling, General & Administrative
$2.1B$-1.9B$1.9B$2.1B$2.4B$2.5B$2.7B$2.4B$2.5B$2.4B
Selling & Marketing Expenses
------------$98.7M$54.1M$71.4M$66.8M
General & Administrative Expenses
------------$2.7B$2.4B$2.5B$2.4B
Promotion & Advertising
------------$98.7M------
Salaries & Wages
------------$-46.7M------
Depreciation & Amortization
$382.6M$385.6M$-814.7M$-747.3M$-489.9M$-464.8M$235.3M$272.4M$254.2M$286.7M
Depreciation & Amortization
$382.6M$385.6M$-814.7M$-747.3M$-489.9M$-464.8M$235.3M------
Amortization
$382.6M$385.6M$-814.7M$-747.3M$-489.9M$-464.8M$5.8B$5.7B$8.4B$9.7B
Other Operating Expenses
--$-10.2M$-112.3M$-185.0M$-241.6M$-232.9M$-4.2M------
OPERATING INCOME
Operating income
$5.0B$5.7B$5.5B$6.0B$7.0B$4.4B$4.6B$3.3B$2.3B$2.9B
EBITDA
$5.4B$5.6B$6.2B$6.9B$7.5B$5.7B$2.9B$4.1B$1.8B$2.8B
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$95.5M$260.0M$250.8M$200.6M$187.4M$222.5M$253.6M------
Intinc
$22.1M$63.4M$78.5M$112.5M$120.0M$42.0M$11.0M------
Net Non-Operating Interest Income/Expense
$-73.4M$-196.6M$-172.3M$-88.1M$-67.4M$-180.5M$-278.9M$157.3M$7.9M$-185.9M
Gain on Sale of Securities
$-36.5M$-3.8M$-30.0M$109.6M$197.7M$675.0M$824.9M------
Other Income/Expense
$174.2M$524.8M$228.3M$13.1M$-157.6M$-781.7M$1.0B$847.2M$315.5M$282.7M
Other Special Charges
$-123.7M$-217.4M$-217.0M$11.0M$83.3M$497.4M$-1.1B$108.2M$-315.5M$-255.0M
SPECIAL ITEMS
Restructring And Mn A Income
$93.4M$33.1M$900.0K$12.0M$1.5M----$131.1M$218.8M$30.2M
Special Income Charges
$-123.9M$-502.7M$-183.6M$-112.2M$6.9M$103.8M--$-131.1M$-218.8M$-30.2M
PRE-TAX INCOME
EBIT
$4.8B$4.9B$5.1B$5.9B$7.1B$5.3B$2.0B$3.6B$1.3B$1.9B
Pre-Tax Income
$4.8B$4.9B$5.1B$5.9B$7.1B$5.0B$1.7B$3.6B$1.3B$1.9B
INCOME TAX
Tax Provision
$1.2B$1.2B$2.5B$1.4B$1.2B$992.3M$52.5M$632.8M$135.3M$273.8M
NET INCOME
Net Income
$3.5B$3.7B$2.5B$4.4B$5.9B$4.0B$1.6B$3.0B$1.2B$1.6B
Net Income (Continuing Operations)
$3.5B$3.7B$2.5B$4.4B$5.9B$4.0B$1.6B$3.0B$1.2B$1.6B
Net Income (Discontinued Operations)
$3.5B$3.7B$2.5B$4.4B$5.9B$4.0B$1.6B$3.0B$1.2B$1.6B
Net Income (Common Stockholders)
$3.5B$3.7B$2.5B$4.4B$5.9B$4.0B$1.6B$3.0B$1.2B$1.6B
Normalized Income
$3.2B$3.7B$3.3B$4.7B$5.6B$4.0B--------
TOTALS
Total Expenses
$5.7B$5.8B$5.9B$6.6B$6.6B$8.4B$7.3B$7.3B$7.5B$6.8B
SHARE & EPS DATA
Average Shares Outstanding
$230.7M$218.4M$212.6M$204.9M$187.1M$160.9M$149.1M$145.3M$144.7M$145.6M
Average Shares Outstanding (Diluted)
$231.2M$218.8M$213.0M$205.3M$187.4M$161.3M$149.6M$146.0M$145.6M$145.9M
Shares Outstanding
$218.7M$216.0M$211.6M$196.7M$174.1M$152.3M$147.0M$144.5M$145.4M$146.4M
Basic EPS
$15.38$16.96$11.94$21.63$31.47$24.86$10.44$20.96$8.02$11.21
Basic EPS (Continuing Operations)
$15.38$16.96$11.94$21.63$31.47$24.86$10.44$20.96$8.02$11.21
Diluted EPS
$15.34$16.93$11.92$21.58$31.42$24.8$10.4$20.87$7.97$11.18
Diluted EPS (Continuing Operations)
$15.34$16.93$11.92$21.58$31.42$24.8$10.4$20.87$7.97$11.18
OTHER METRICS
Earnings from equity interest
------------$34.9M------
Earnings From Equity Interest Net Of Tax
------------$34.9M------
Gain On Sale Of Business
--------$-55.3M$92.5M--------
Gain On Sale Of P P E
--------------$503.7M----
Interest Expense Operating
------------$-280.8M------
Minority Interests
$-46.2M$7.1M$-131.0M$-43.3M--$-59.9M$-171.5M$85.3M$-400.0K--
Net Income From Other Gains Losses
------------$-34.9M------
Other Gand A
------------$2.7B$2.4B$2.5B$2.4B
Othspecchg
--$-454.8M$-120.0M$-112.5M--$-75.0M--------
Restruct
$93.4M$33.1M$900.0K$12.0M$1.5M----$131.1M$218.8M$30.2M

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2BIIB$132.22-0.3%1.08M
3
4
5
6

Get Biogen Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.